Concepedia

Antti Haapalinna

AH

60

Publications

2.8K

Citations

32

H-Index

1989

Active since

Affiliations

Orion Corporation (Finland)(Current)

University of Eastern Finland

Orion Corporation (United Kingdom)

University of Turku

Kuopio University Hospital

Antti Haapalinna is an author at Orion Corporation (Finland) specializing in medicine, neuroscience, and neuropharmacology.

ORCID

Top concepts

Publications per year

1989–2017

60

Publications

60

Adrenergic α<sub>2C</sub>-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice

Jukka Sallinen, Antti Haapalinna, Timo Viitamaa et al. · Journal of Neuroscience · 1998 · 214 citations · Full text

, , +19

Genetic Alteration of α2C-Adrenoceptor Expression in Mice: Influence on Locomotor, Hypothermic, and Neurochemical Effects of Dexmedetomidine, a Subtype-Nonselective α2-Adrenoceptor Agonist

Jukka Sallinen, Richard E. Link, Antti Haapalinna et al. · Molecular Pharmacology · 1997 · 170 citations

Neuroprotective Effects of Dexmedetomidine in the Gerbil Hippocampus after Transient Global Ischemia 

Johanna Kuhmonen, J Pokorný, Riitta Miettinen et al. · Anesthesiology · 1997 · 146 citations · Full text

Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels

Jukka Sallinen, Antti Haapalinna, Ewen MacDonald et al. · Molecular Psychiatry · 1999 · 125 citations

, , +14

Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia

Jukka Jolkkonen, Kirsi Puurunen, Jari Koıstınaho et al. · European Journal of Pharmacology · 1999 · 115 citations

, , +12

Rows per page

1–5 of 60